Data / Form D filings / 60 DEGREES PHARMACEUTICALS, INC.
60 DEGREES PHARMACEUTICALS, INC.: Form D filings
60 DEGREES PHARMACEUTICALS, INC., a pharmaceuticals company in Washington, DC, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on February 12, 2025, reports $1.1 million sold of a $1.1 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1025 CONNECTICUT AVENUE NW, SUITE 1000, Washington, DC, 20036
- Phone
- (202) 327-5422
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1946563
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | New notice | $1,075,003 | $1,075,003 | 4 | Feb 5, 2025 | sec.gov | |
| Feb 11, 2025 | New notice | $1,043,002 | $1,043,002 | 4 | Jan 28, 2025 | sec.gov | |
| May 24, 2023 | New notice | Indefinite | $1,755,000 | 10 | May 19, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Geoffrey S. Dow | Executive Officer, Director |
Every Form D from the week of Feb 10, 2025 · All recent filings in District of Columbia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what 60 DEGREES PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.